vs
CARRIAGE SERVICES INC（CSV）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是CARRIAGE SERVICES INC的1.9倍（$197.9M vs $105.5M），CARRIAGE SERVICES INC净利率更高（11.6% vs 6.7%，领先4.9%），REPLIGEN CORP同比增速更快（13.6% vs 8.0%），REPLIGEN CORP自由现金流更多（$17.6M vs $6.2M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 1.0%）
怡和Cycle & Carriage有限公司是怡和集团在东南亚的投资控股公司，目前该集团持有其75%的股份，是怡和集团在东南亚区域开展资本布局与投资业务的核心平台。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
CSV vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.9倍
$105.5M
营收增速更快
RGEN
高出5.7%
8.0%
净利率更高
CSV
高出4.9%
6.7%
自由现金流更多
RGEN
多$11.3M
$6.2M
两年增速更快
RGEN
近两年复合增速
1.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $105.5M | $197.9M |
| 净利润 | $12.3M | $13.3M |
| 毛利率 | 34.8% | 52.5% |
| 营业利润率 | 23.3% | 9.0% |
| 净利率 | 11.6% | 6.7% |
| 营收同比 | 8.0% | 13.6% |
| 净利润同比 | 24.5% | 143.9% |
| 每股收益（稀释后） | $0.76 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSVRGEN
| Q4 25 | $105.5M | $197.9M | ||
| Q3 25 | $102.7M | $188.8M | ||
| Q2 25 | $102.1M | $182.4M | ||
| Q1 25 | $107.1M | $169.2M | ||
| Q4 24 | $97.7M | $174.1M | ||
| Q3 24 | $100.7M | $154.9M | ||
| Q2 24 | $102.3M | $154.1M | ||
| Q1 24 | $103.5M | $151.3M |
净利润CSVRGEN
| Q4 25 | $12.3M | $13.3M | ||
| Q3 25 | $6.6M | $14.9M | ||
| Q2 25 | $11.7M | $14.9M | ||
| Q1 25 | $20.9M | $5.8M | ||
| Q4 24 | $9.9M | $-30.3M | ||
| Q3 24 | $9.9M | $-654.0K | ||
| Q2 24 | $6.3M | $3.3M | ||
| Q1 24 | $7.0M | $2.1M |
毛利率CSVRGEN
| Q4 25 | 34.8% | 52.5% | ||
| Q3 25 | 35.3% | 53.2% | ||
| Q2 25 | 35.2% | 50.0% | ||
| Q1 25 | 35.3% | 53.6% | ||
| Q4 24 | 34.4% | 26.1% | ||
| Q3 24 | 35.2% | 50.0% | ||
| Q2 24 | 36.2% | 49.8% | ||
| Q1 24 | 36.0% | 49.5% |
营业利润率CSVRGEN
| Q4 25 | 23.3% | 9.0% | ||
| Q3 25 | 17.0% | 8.9% | ||
| Q2 25 | 23.5% | 7.6% | ||
| Q1 25 | 29.5% | 3.9% | ||
| Q4 24 | 21.6% | -17.7% | ||
| Q3 24 | 22.7% | -5.1% | ||
| Q2 24 | 18.0% | 1.0% | ||
| Q1 24 | 18.8% | 1.3% |
净利率CSVRGEN
| Q4 25 | 11.6% | 6.7% | ||
| Q3 25 | 6.4% | 7.9% | ||
| Q2 25 | 11.5% | 8.2% | ||
| Q1 25 | 19.5% | 3.4% | ||
| Q4 24 | 10.1% | -17.4% | ||
| Q3 24 | 9.8% | -0.4% | ||
| Q2 24 | 6.1% | 2.2% | ||
| Q1 24 | 6.7% | 1.4% |
每股收益（稀释后）CSVRGEN
| Q4 25 | $0.76 | $0.24 | ||
| Q3 25 | $0.41 | $0.26 | ||
| Q2 25 | $0.74 | $0.26 | ||
| Q1 25 | $1.34 | $0.10 | ||
| Q4 24 | $0.62 | $-0.55 | ||
| Q3 24 | $0.63 | $-0.01 | ||
| Q2 24 | $0.40 | $0.06 | ||
| Q1 24 | $0.45 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $254.8M | $2.1B |
| 总资产 | $1.3B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资CSVRGEN
| Q4 25 | $1.7M | $767.6M | ||
| Q3 25 | $1.2M | $748.7M | ||
| Q2 25 | $1.4M | $708.9M | ||
| Q1 25 | $4.6M | $697.2M | ||
| Q4 24 | $1.2M | $757.4M | ||
| Q3 24 | $1.3M | $784.0M | ||
| Q2 24 | $1.5M | $809.1M | ||
| Q1 24 | $1.7M | $780.6M |
总债务CSVRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CSVRGEN
| Q4 25 | $254.8M | $2.1B | ||
| Q3 25 | $242.1M | $2.1B | ||
| Q2 25 | $235.4M | $2.1B | ||
| Q1 25 | $223.1M | $2.0B | ||
| Q4 24 | $208.6M | $2.0B | ||
| Q3 24 | $198.1M | $2.0B | ||
| Q2 24 | $187.9M | $2.0B | ||
| Q1 24 | $179.6M | $2.0B |
总资产CSVRGEN
| Q4 25 | $1.3B | $2.9B | ||
| Q3 25 | $1.3B | $2.9B | ||
| Q2 25 | $1.3B | $2.9B | ||
| Q1 25 | $1.3B | $2.9B | ||
| Q4 24 | $1.3B | $2.8B | ||
| Q3 24 | $1.3B | $2.8B | ||
| Q2 24 | $1.3B | $2.9B | ||
| Q1 24 | $1.3B | $2.8B |
负债/权益比CSVRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.1M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $6.2M | $17.6M |
| 自由现金流率自由现金流/营收 | 5.9% | 8.9% |
| 资本支出强度资本支出/营收 | 7.5% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.15× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $40.1M | $93.9M |
8季度趋势，按日历期对齐
经营现金流CSVRGEN
| Q4 25 | $14.1M | $25.7M | ||
| Q3 25 | $24.7M | $48.1M | ||
| Q2 25 | $8.1M | $28.6M | ||
| Q1 25 | $13.8M | $15.0M | ||
| Q4 24 | $9.3M | $39.2M | ||
| Q3 24 | $20.9M | $49.3M | ||
| Q2 24 | $2.2M | $42.2M | ||
| Q1 24 | $19.7M | $44.7M |
自由现金流CSVRGEN
| Q4 25 | $6.2M | $17.6M | ||
| Q3 25 | $18.0M | $43.4M | ||
| Q2 25 | $5.2M | $21.5M | ||
| Q1 25 | $10.6M | $11.4M | ||
| Q4 24 | $4.9M | $33.6M | ||
| Q3 24 | $16.2M | $42.3M | ||
| Q2 24 | $-1.4M | $37.4M | ||
| Q1 24 | $16.2M | $36.4M |
自由现金流率CSVRGEN
| Q4 25 | 5.9% | 8.9% | ||
| Q3 25 | 17.5% | 23.0% | ||
| Q2 25 | 5.1% | 11.8% | ||
| Q1 25 | 9.9% | 6.8% | ||
| Q4 24 | 5.0% | 19.3% | ||
| Q3 24 | 16.1% | 27.3% | ||
| Q2 24 | -1.4% | 24.3% | ||
| Q1 24 | 15.6% | 24.0% |
资本支出强度CSVRGEN
| Q4 25 | 7.5% | 4.1% | ||
| Q3 25 | 6.5% | 2.5% | ||
| Q2 25 | 2.8% | 3.9% | ||
| Q1 25 | 3.0% | 2.1% | ||
| Q4 24 | 4.5% | 3.2% | ||
| Q3 24 | 4.6% | 4.5% | ||
| Q2 24 | 3.5% | 3.1% | ||
| Q1 24 | 3.4% | 5.5% |
现金转化率CSVRGEN
| Q4 25 | 1.15× | 1.93× | ||
| Q3 25 | 3.76× | 3.23× | ||
| Q2 25 | 0.69× | 1.92× | ||
| Q1 25 | 0.66× | 2.57× | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 0.34× | 12.70× | ||
| Q1 24 | 2.83× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSV
| Propertyand Merchandise | $47.8M | 45% |
| Cemetery Interment Rights | $24.8M | 23% |
| Merchandise | $18.9M | 18% |
| Other Revenue | $10.2M | 10% |
| Other | $3.9M | 4% |
RGEN
暂无分部数据
